Microbiology · Year 2 · from Microbiology

Case 2: Infant Botulism

Presentation

A 4-month-old previously healthy infant is brought to the emergency department by her parents who are concerned that she has become progressively weak and "floppy" over the past 3 days. They first noticed she was feeding poorly, with weak suck and difficulty swallowing. She has become increasingly constipated. Today they noticed she seems to have a weak cry and can barely hold her head up.

The mother mentions she has been giving the baby honey mixed with water as a home remedy for colic, based on her grandmother's recommendation.

Physical examination reveals an alert but hypotonic infant with poor head control, ptosis, weak facial expression, diminished gag reflex, and generalized hypotonia with decreased deep tendon reflexes. Pupils are sluggishly reactive to light.

Clinical Image

Comparison of clostridial neurotoxins - understanding the mechanisms that produce opposite clinical effects despite similar molecular targets.

Image Source: Lecture image - toxin mechanisms

Questions

  1. What is the diagnosis, and how did this infant acquire the illness?
  1. Why does botulinum toxin cause flaccid paralysis while tetanus toxin (which has a similar molecular mechanism) causes spastic paralysis?
  1. What is the characteristic pattern of neurological findings in botulism?
  1. What is the treatment for infant botulism, and why does it differ from treatment for foodborne botulism in adults?

Answers

  1. Diagnosis and acquisition:

Diagnosis: Infant botulism caused by Clostridium botulinum toxin production in the intestinal tract.

Mechanism of acquisition:

  • Unlike foodborne botulism (ingestion of preformed toxin), infant botulism results from intestinal colonization
  • The infant ingested C. botulinum spores present in the honey
  • Spores germinated in the infant's intestinal tract and produced toxin in vivo
  • The immature infant gut microbiome lacks colonization resistance (protective normal flora) that prevents germination in older children and adults

Honey warning: This is why honey should not be given to infants under 12 months of age - it commonly contains C. botulinum spores. Most infant botulism cases are from environmental spore exposure, but honey is a preventable source.

  1. Flaccid vs. spastic paralysis:

Both toxins are zinc metalloproteases that cleave SNARE proteins required for neurotransmitter vesicle fusion. The difference lies in WHERE they act:

| Feature | Botulinum Toxin | Tetanus Toxin | |---------|-----------------|---------------| | Site of action | Neuromuscular junction (peripheral) | Spinal cord inhibitory interneurons (central) | | Neurotransmitter blocked | Acetylcholine (excitatory at NMJ) | Glycine and GABA (inhibitory) | | Result | Motor neurons cannot stimulate muscles | Motor neurons have no inhibition | | Clinical effect | Flaccid paralysis | Spastic paralysis |

Botulinum toxin remains at the peripheral nerve terminal where it was absorbed. Tetanus toxin undergoes retrograde axonal transport to reach central inhibitory neurons.

  1. Pattern of neurological findings in botulism:

Descending, symmetric, flaccid paralysis with prominent bulbar findings:

  1. Cranial nerve involvement first ("bulbar" findings):
  • Ptosis, diplopia, blurred vision (extraocular muscles)
  • Facial weakness
  • Dysphagia, dysarthria (pharyngeal muscles)
  • Fixed or sluggishly reactive pupils (autonomic)
  1. Descends to skeletal muscles:
  • Neck weakness → arm weakness → trunk → legs
  • Respiratory muscle involvement (most dangerous)
  1. Key clinical features:
  • Symmetric
  • No sensory deficits
  • Clear mental status (toxin doesn't cross blood-brain barrier)
  • Autonomic features: constipation, urinary retention, dry mouth

Infant botulism specifically = "Floppy baby syndrome":

  • Poor feeding, weak suck
  • Weak cry
  • Loss of head control
  • Constipation (often first symptom)
  • Generalized hypotonia
  1. Treatment differences:

Infant botulism treatment:

  • BabyBIG (Botulism Immune Globulin Intravenous): Human-derived IgG containing anti-botulinum antibodies
  • Safe for infants with no risk of hypersensitivity
  • Significantly reduces hospitalization duration, ICU stay, and need for mechanical ventilation
  • Cost is high but cost-effective given reduced hospital stay

Adult foodborne/wound botulism treatment:

  • Heptavalent botulinum antitoxin (HBAT): Equine-derived, neutralizes all 7 serotypes
  • Risk of hypersensitivity reactions (serum sickness) - requires monitoring

Why the difference?

  • BabyBIG is human-derived IgG (no hypersensitivity risk)
  • HBAT is equine-derived (horse serum antibodies)
  • Both must be given early - they neutralize circulating toxin but cannot reverse already-bound toxin

Supportive care for all forms:

  • Mechanical ventilation often required for weeks to months
  • Recovery depends on regeneration of nerve terminals and formation of new neuromuscular junctions
  • Antibiotics NOT routinely given for infant botulism (may lyse bacteria and release more toxin)

All cases for this lecture as Markdown